Blog

Randy Epstein, MD and Parag Majmudar, MD, both Corneal Specialists at Chicago Cornea Consultants, were recently granted approval to treat patients as young as 12 years old. Collagen cross-linking (CXL) is a simple, relatively new treatment that attempts to stop the progression of Keratoconus. The combination of the UV light and the riboflavin activates molecules that strengthen the bonds between and within collagen fibrils in the cornea. This stiffens and strengthens the cornea which causes the cornea to become less steep, resulting in visual improvement.

Looking for a neutral website to answer your eye care questions?  Visit the NEW “ASCRS patient education website” at www.EyeSurgeryEducation.org  Educating yourself helps the physicianserve you best, and assists you in making your important decisions on your eye health.

Parag A. Majmudar, MD has been recognized to join the PS250 community. PS205 is a list of surgeons the publisher and editors of Premier Surgeon have identified as leading innovators in the field of premier IOL (Intraocular Lens) implant surgery. Being amongst this very select group further acknowledges Dr. Majmudar as one of the leaders in premier lens implantation.

This progressive field enables cataract and refractive lens exchange patients multitude of implant options to better their lifestyles after surgery.  These options include, Multifocal, Accommodative, and Toric (astigmatic) styles.

CXL (Collagen Cross-Linking) USA invited Randy Epstein, MD and Parag Majmudar, MD to join the “CXL USA Study Group”. Since then, Chicago Cornea Consultants has been one of a select few, and the only practice in the Midwest, to be allowed to perform CXL treatments on an approved study basis.

Collagen Cross-Linking has been performed internationally for many years. This is the only procedure known to halt the progression of the sight threatening condition, keratoconus.  It can be used to treat various forms of keratoconus. This is an in office procedure in which both eyes  can be treated on the same day.

For more information visit their site at www.cxl-usa.com

Dr. Parag A. Majmudar, a corneal specialist at Chicago Cornea Consultants lectured at the “Surface Ablation, Femto-Lasers and Cross-Linking Congress, 2010″.  This international meeting, held on April 10th in Weston Florida, was attended by the top Ophthalmologists.  Peer discussions at the conference aid to further improve procedure techniques worldwide.  It is an honor to be invited to be a speaker as well as extremely beneficial to attend.

“Dr. Epstein was interviewed on ABC’s local affiliate, WLS-TC Channel 7, which was broadcast on the 5:00 pm news on 5/21/10, regarding Rush’s acquisition of state-of-the art confocal and OCT microscopes, along with a Pentacam corneal imaging system.  These are useful in the diagnosis of difficult corneal infections, such as those caused by Acanthamoeba.  This equipment purchase was made possible by a donation made to Rush by a grateful patient.”

Chicago Cornea Consultants launches a new clinical trial of collagen cross linking (CXL) for keratoconus.   CXL is a relatively non-invasive procedure that is being performed in virtually every country as a standard treatment for keratoconus.  It has been shown to stop the progression of keratoconus.  However, it is not a procedure approved in the United States.  Drs. Majmudar and Epstein have been selected as one of eight sites throughout the USA and are actively enrolling patients for this study.  If you or a loved one has keratoconus, this treatment may be appropriate.  CXL may help slow down or even stop the progression of keratoconus, and may possibly even prevent the need for a corneal transplant.  For more information, please contact Jim Nykaza at 847.882.5900.

In December 2009, Dr. Majmudar was invited and travelled to Agra, India as one of 5 internationally invited speakers to give several lectures at the Advanced Course in Cataract and Refractive Surgery.

Slack, Inc. Publishers recently released “Cornea Handbook,” edited by Dr. Majmudar and colleagues. The book will ideally serve as a handy and practical, yet comprehensive reference guide for accessing the fundamentals of corneal conditions, surgeries, and imaging technologies. The book is geared toward ophthalmologists, optometrists, ophthalmology residents and medical students.

Parag A. Majmudar, MD, is a respected Chicagoland Corneal Specialist and LASIK surgeon, senior partner of Chicago Cornea Consultants and Associate Professor of Ophthalmology at Rush University Medical Center in Chicago. At the American Academy of Ophthalmology Annual Meeting, San Francisco, CA, October 2009, he participated as Invited Faculty at the “Cornea and Anterior Segment Disasters: Bringing them back from the Precipice” meeting, and Invited Instructor for the “Lasik Course”.

Dr. Majmudar also acted as Chairman, Refractive Surgery Subcommittee, American Academy of Ophthalmology, 2009 and a member of the Annual Meeting Program Committee, February 2009. He is a member of the American Society of Cataract Refractive Surgery’s Refractive Surgery Clinical Committee.  He also serves on the editorial boards of the Journal of Refractive Surgery, Cataract and Refractive Surgery Today and Ocular Surgery News.

Dr. Majmudar is a Fellowship trained in Cornea, External Disease and Refractive Surgery who is invited to lecture both nationally and internationally. He is one of 4 international surgeons to be invited to the Annual Meeting of the Refractive Implant and IOL Society to be held in Agra, India in December 2009.  He was was one of the first surgeons in the United States to perform the Veriflex phakic implant (used for high myopes that cannot have LASIK), and helped pioneer the use of MMC for the prevention and treatment of corneal scarring in association with certain refractive surgical procedures. He recently co-authored an article entitled “Reduced Application Time for Prophylactic Mitomycin-C in Photorefractive Keratectomy” which will be published in Ophthalmology, 2010.